A detailed history of Macquarie Group LTD transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Macquarie Group LTD holds 35,100 shares of JAZZ stock, worth $4.31 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
35,100
Previous 35,100 -0.0%
Holding current value
$4.31 Million
Previous $3.75 Million 4.43%
% of portfolio
0.0%
Previous 0.0%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

SELL
$103.94 - $118.98 $292,591 - $334,928
-2,815 Reduced 7.42%
35,100 $3.75 Million
Q1 2024

May 14, 2024

SELL
$115.19 - $132.77 $42,274 - $48,726
-367 Reduced 0.96%
37,915 $4.57 Million
Q4 2023

Feb 14, 2024

BUY
$114.26 - $136.0 $52,673 - $62,696
461 Added 1.22%
38,282 $4.71 Million
Q3 2023

Nov 14, 2023

SELL
$122.0 - $145.31 $74,054 - $88,203
-607 Reduced 1.58%
37,821 $4.9 Million
Q2 2023

Aug 14, 2023

SELL
$122.5 - $147.16 $22,785 - $27,371
-186 Reduced 0.48%
38,428 $4.76 Million
Q1 2023

May 15, 2023

BUY
$133.98 - $160.47 $1.1 Million - $1.32 Million
8,237 Added 27.12%
38,614 $5.65 Million
Q4 2022

Feb 21, 2023

BUY
$129.72 - $159.85 $390,976 - $481,787
3,014 Added 11.01%
30,377 $4.84 Million
Q3 2022

Nov 14, 2022

SELL
$126.59 - $161.18 $5.7 Million - $7.26 Million
-45,046 Reduced 62.21%
27,363 $3.65 Million
Q2 2022

Aug 15, 2022

BUY
$141.59 - $168.66 $2.97 Million - $3.54 Million
21,006 Added 40.87%
72,409 $11.3 Million
Q1 2022

May 16, 2022

BUY
$129.64 - $160.7 $2.61 Million - $3.23 Million
20,096 Added 64.19%
51,403 $8 Million
Q4 2021

Feb 11, 2022

SELL
$119.87 - $145.67 $24.9 Million - $30.3 Million
-207,978 Reduced 86.92%
31,307 $3.99 Million
Q3 2021

Nov 12, 2021

SELL
$128.64 - $184.79 $4.53 Million - $6.51 Million
-35,243 Reduced 12.84%
239,285 $31.2 Million
Q2 2021

Aug 13, 2021

BUY
$160.2 - $186.42 $39.5 Million - $46 Million
246,607 Added 883.23%
274,528 $48.8 Million
Q4 2020

Feb 16, 2021

SELL
$140.71 - $165.05 $67,962 - $79,719
-483 Reduced 1.7%
27,921 $4.61 Million
Q3 2020

Nov 13, 2020

BUY
$105.46 - $144.13 $613,460 - $838,404
5,817 Added 25.75%
28,404 $4.05 Million
Q2 2020

Aug 11, 2020

BUY
$95.68 - $121.88 $466,631 - $594,408
4,877 Added 27.54%
22,587 $2.49 Million
Q4 2019

Feb 14, 2020

BUY
$117.65 - $153.73 $401,186 - $524,219
3,410 Added 23.85%
17,710 $2.64 Million
Q2 2019

Aug 14, 2019

SELL
$125.55 - $144.48 $188,325 - $216,719
-1,500 Reduced 9.49%
14,300 $2.04 Million
Q1 2019

May 15, 2019

BUY
$121.81 - $142.95 $182,715 - $214,424
1,500 Added 10.49%
15,800 $2.26 Million
Q4 2018

Feb 15, 2019

BUY
$115.94 - $166.74 $1.33 Million - $1.92 Million
11,500 Added 410.71%
14,300 $1.77 Million
Q3 2018

Nov 15, 2018

BUY
$161.01 - $180.57 $241,515 - $270,855
1,500 Added 115.38%
2,800 $471,000
Q2 2018

Aug 14, 2018

SELL
$146.33 - $183.18 $58,532 - $73,272
-400 Reduced 23.53%
1,300 $224,000
Q1 2018

May 11, 2018

SELL
$135.59 - $157.16 $13,559 - $15,716
-100 Reduced 5.56%
1,700 $256,000
Q4 2017

Feb 15, 2018

BUY
$131.06 - $150.39 $144,166 - $165,428
1,100 Added 157.14%
1,800 $965,000
Q3 2017

Nov 08, 2017

BUY
$142.62 - $155.6 $99,834 - $108,920
700
700 $103,000

Others Institutions Holding JAZZ

About Jazz Pharmaceuticals plc


  • Ticker JAZZ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,680,700
  • Market Cap $7.7B
  • Description
  • Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...
More about JAZZ
Track This Portfolio

Track Macquarie Group LTD Portfolio

Follow Macquarie Group LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Macquarie Group LTD with notifications on news.